Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4

27 Apr 2020

Abstract excerpt

BACKGROUND: Alcoholic liver disease (ALD) is a public health concern that is the cause of half of all cirrhosis-related deaths. Early detection of fibrosis, ideally in the precirrhotic stage, is a key strategy for improving ALD outcomes and for preventing progression to cirrhosis. Previous studies identified the blood-borne marker human microfibrillar-associated protein 4 (MFAP4) as a biomarker for detection of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alcohol Consumption and Health Effects
Share to Liver Disease and Transplantation
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32339377
DOI: 10.1111/liv.14491

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4PMID 32339377Read ↗

Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient CohortSemantic proximity Read ↗

Early Identification of At-Risk Patients: Proteomic Signature Predicts Progression to Decompensated CirrhosisSemantic proximity Read ↗

A paired liver biopsy and plasma proteomics study reveals circulating biomarkers for alcohol-related liver diseaseSemantic proximity Read ↗

Molecular Insights into Alcohol-Induced Hepatocarcinogenesis and Comorbidities: Unravelling the Clinical Markers SymphonySemantic proximity Read ↗

New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol HistorySemantic proximity Read ↗

Demarcating the Development of Cirrhosis and Its Complications via Plasma Proteomic Features in an Asymptomatic PopulationSemantic proximity Read ↗

A Multi-Biomarker Prediction Model Integrating Genetics, Hematological Indices, and Fibrosis Stage to Forecast Non-Response in HCV Genotype 4Semantic proximity Read ↗

Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study.Semantic proximity Read ↗

Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.Semantic proximity Read ↗

Association Between Immunologic Markers And Cirrhosis In Individuals With Chronic Hepatitis BSemantic proximity Read ↗

A plasma peptidomic signature reveals extracellular matrix remodeling and predicts prognosis in alcohol-related hepatitisSemantic proximity Read ↗

Enzyme-Linked Immunosorbent Assay Characterization of Basal Variation and Heritability of Systemic Microfibrillar-Associated Protein 4Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.